Kiddir

Esomeprazole, the active ingredient in Kiddir, is a proton pump inhibitor presented as an oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis and ulcer conditions in adult patients.

GNH USA supplies Kiddir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole is used to manage conditions caused by excess gastric acid production. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates repair of erosive lesions in the oesophagus. - NSAID‑induced gastric ulcer: prevents ulcer formation and supports mucosal healing. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid.

Adverse reactions may occur with esomeprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Low magnesium levels (hypomagnesemia): can lead to muscle cramps or cardiac arrhythmia.

Before initiating therapy, consider the following precautions. - Renal function assessment: adjust use in severe renal impairment. - Magnesium monitoring: check serum levels during prolonged treatment. - Liver disease caution: use with care in patients with hepatic impairment. - Drug interaction vigilance: avoid concomitant use with medications that may reduce efficacy. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Esomeprazole may interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - HIV protease inhibitors (e.g., ritonavir): altered metabolism leading to reduced drug levels.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: potential rise in serum digoxin concentration.